Capital BlueCross HMO Plan is Ranked No. 1 in Pennsylvania for Member Sa...(ding health insurance coverage to nearly...),Health
Navigation Links
Capital BlueCross HMO Plan is Ranked No. 1 in Pennsylvania for Member Satisfaction
Date:12/4/2007
ding health insurance coverage to nearly one million people in central Pennsylvania and the Lehigh Valley. Capital BlueCross is committed to making health insurance simple for its customers and members through all the stages of life by offering nationally acclaimed customer service and a full range of innovative benefit programs at competitive prices.
The company has been providing health security to the people and communities of central Pennsylvania and the Lehigh Valley for 70 years and employs more than 2,300 people in the region.
Capital BlueCross is an independent licensee of the Blue Cross and Blue Shield Association.
More information about Capital BlueCross can be found at http://www.capbluecross.com.
The PHC4 report is available at http://www.phc4.org/reports/medicarehmo/2007.
'/>"/>
| SOURCE Capital BlueCross Copyright©2007 PR Newswire. All rights reserved |
Related medicine news :
1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
(Date:5/15/2008)...t safety in hospitals focus of 48 NQF-endorsed mea... -- Recognizing that patient,safety remains a majo...y,Forum (NQF) today endorsed 48 voluntary consensu...f acute care hospitals, including measures,address...evention and care,of venous thromboembolism., "It...
(Date:5/15/2008)...es not appear to help quality of life for lung can...ay 15 (HealthDay News) -- Adding chemotherapy to o...thelioma, a lung cancer usually linked to asbestos...val or quality of life. , Malignant pleural mes...er of the protective lining that covers the lungs....
(Date:5/15/2008)...ommends Governor Paterson,s leadership in proposin...ncy, ALBANY, N.Y., May 15 /PRNewswire-USNewswire/...t interest in passing the Governor,s prescription,... influence that,pharmaceutical companies have over...ers, pocket books but the treatment they receive.,...
(Date:5/15/2008)...D, Calif., May 15 /PRNewswire-FirstCall/ -- (Nasda...ompany") today announced that, on May,12, 2008, it...stating that,the Company,s requests for continued ...ed. The NASDAQ noted that the Company did not prov...hieve near term compliance with,the continued list...
Breaking Medicine News(10 mins):Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 2Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 3Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 4Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 5Health News:Chemo for Mesothelioma Offers Limited Survival Benefits 2Health News:AARP Statement on Governor's Bill for Prescription Drug Marketing Reform and Transparency 2Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 2Health News:WorldHeart Announces Possible Delisting Action by NASDAQ 3... next drug that can stop the growth and spread of ...an enzyme known as mammalian target of rapamycin (...not divide anymore or move o a different location ... the cells ability to get nourishment from the blo...
..., it may help if they take corticosteroid medicati... medication regularly. People who took corticoster...ad the same rate of severe attacks and asthma rela...who were treated with the standard treatment of da...
...dren in their teens and women are the most affecte...the sun. // In the report that was published in th...ed 340 volunteers to wear a wristwatch that is act...t measures time-stamped UVR doses. The volunteers...
...t caffeine in coffee can keep us awake, even when ...happens.// Scientists from University of Texas So...xactly how caffeine keeps us awake. As the brain ...hemical compound called adenosine sends impulses t...
Other Medicine News:(Date:5/14/2008)...ate to lead expansion of Cytel,s adaptiv...IDGE, Mass., May 14 /- Cytel Inc., a ... and specialized statistical software,today annou...sident,Adaptive Trials., Judith Quinlan brings o...Cytel team. Prior to joining Cytel Judith spent 10...
(Date:5/14/2008)...stCall/ -- The Quigley,Corporation (Nasdaq: QGLY ...d by its wholly owned subsidiary, Quigley Pharma I...he anti-viral activity of its compound,QR448(a). T...en infected,with Infectious Bronchitis Virus (IBV)...is efficacious against an IBV challenge in two wee...
(Date:5/13/2008)...wire/ -- In women at increased,risk for breast can...routine mammography revealed 28 percent more cance... ultrasound exam substantially increased the,rates...es, according to an,American College of Radiology ... 14, 2008 issue of the Journal of American Medical...
(Date:5/13/2008)...uesday, May 13 at 1:00 p.m. EDT ...ENLO PARK, Calif., May 13 /PRNewswire-FirstCall/,-...itive six-month follow-up,data from the CUSTOM III...icacy of the Custom NX(R) drug eluting stent (DES)...y artery disease., The CUSTOM III clinical trial ...
Breaking Medicine Technology:Judith Quinlan Joins Cytel as Vice President, Adaptive Trials 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 2Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer 3XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4January American Naturalist highlights 9100 1January American Naturalist highlights 9100 2January American Naturalist highlights 9100 3January American Naturalist highlights 9100 4January American Naturalist highlights 9100 5January American Naturalist highlights 9100 6January American Naturalist highlights 9100 7January American Naturalist highlights 9100 8January American Naturalist highlights 9100 9January American Naturalist highlights 9100 10January American Naturalist highlights 9100 11January American Naturalist highlights 9100 12January American Naturalist highlights 9100 13Surviving childhood cancer the success story 9097 1RxElite Registration Statement Suspended 9094 1RxElite Registration Statement Suspended 9094 2Arizona Patient Protection Act Introduced 9091 1Arizona Patient Protection Act Introduced 9091 2Arizona Patient Protection Act Introduced 9091 3[0] Judith Quinlan Joins Cytel as Vice President, Adaptive Trials[0] Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization[0] Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer[0] XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
...rated with signs of durable,disease control in adv..., 2007 /PRNewswire-FirstCall/ -- IDM,Pharma, Inc. ...I,UVIDEM (IDD-3) melanoma vaccine clinical trial (...ll tolerated with evidence of,efficacy and inducti... metastatic melanoma. , The data were presented by...
...sented at ENDO 2007 , ,- Regulatory approvals for ...ruitment in Europe , ,MONTREAL, QUEBEC -- (MARKET ...TH) reported today that 26-week data from,its firs...ipodystrophy were presented today in Toronto at EN...ty. The presentation was made,by Dr. Steve Grinspo...
Other Medicine Technology:IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 2IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 3IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 4IDM Pharma Presents Preliminary Results from Phase II UVIDEM,Melanoma Vaccine Clinical Trial 5Theratechnologies: TH9507 Phase 3 Clinical Update 2Theratechnologies: TH9507 Phase 3 Clinical Update 3Yankauer (Andrews) suction tube
Yankauer
Ferguson-Frazier suction tube # 5
Ferguson-Frazier suction tube # 3
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |